Blog
Blog
Charles River Laboratories Signs Binding Offer to Acquire Citoxlab
Citoxlab is a premier provider of safety assessment and discovery services to the pharmaceutical, biotechnology, medical device, and chemical industries. The proposed acquisition of Citoxlab would further strengthen Charles River’s position as the leading global early-stage CRO by expanding its scientific portfolio and geographic footprint, which would enhance the Company’s ability to partner with clients across the drug discovery and development continuum.
